Please help Dr. Marshall maintain the website
by giving a small donation.

Marshall's Treatments

The information given below & the tabulated information in the next section was compiled by the following authors & others (named in each section).

 

Barry J. Marshall MB.BS
FRACP, Nobel Laureate

Loren Laine M.D

Dr Aruni.H.W. Mendis
(Phd.,Dip.Imp..Coll..)

The data was comparable with that presented at the American Gastrointestinal Association conference held in Washington D.C. in May 1997. Most Data are still valid as at July 2006.

Please Note that 20mg omeprazole and 30 mg lansoprazole are equivalent in most treatments.

 

Conventional First-Line Triple Therapies-(Twice-Daily PPI-Based Triple Therapies)


Cure rate 90%:with 2 weeks treatment  in the U.S.; 1 week Treatment outside U.S.

  • Omeprazole 20 mg bid or Lansoprazole 30 mg bid
  • Clarithromycin 500 mg bid 
  • Amoxicillin 1 g bid
  • or Metronidazole 500 mg bid if Amoxicillin intolerant

 

Traditional Bismuth-Based Triple Therapy


Cure rate 80% with 2 weeks Treatment (USA) ;

Cure rate outside U.S.A.: 90% with 1-2 weeks Treatment

  • Bismuth subsalicylate (Pepto-Bismol) 2 ( How many mg???) tablets qid in U.S.
    • OR
  • De-Nol [Colloidal bismuth subcitrate ]* 120mg qid outside U.S.)
    • Tetracycline 500 mg qid
    • Metronidazole 400 mg qid 
    • Proton  Pump Inhibitor (20mg Omeprazole bid or 30 mg lansoprazole. bid

*De-Nol (Colloidal Bismuth Subcitrate) is Available in Australia Under the TGA's Special Access Scheme (SAS)  Contact Tri-Med Distributors P/L; Email sales@trimed.com.au; Ph. +61 8 9388 1444

 

Furazolidone & Bismuth Based (Second Line)  Quadruple Therapies


Cure Rate >92% Duration of Treatment 14 days

  • Furazolidone 200mg bid
  • Colloidal Bismuth Subcitrate (De-Nol) 120mg qid
  • Amoxicillin 1000mg bid
  • 20mg Omeprazole bid OR 30 mg lansoprazole. bid

 

Third-Line Quadruple "Salvage Therapy" ( Marshall Therapy)


  • Ciprofloxacin 500mg bid
  • Rifabutin* 150mg bid
  • Omeprazole 40mg tds (six times the normal dose)
  • Amoxycillin 1000mg tds

* Rifabutin is only available through a Hospital Pharmacy

 

Other Triple Therapies - Twice-Daily RBC-Based Triple Therapy


Cure rate 90% with  2 weeks treatment.

  • Ranitidine bismuth citrate (RBC)* 400 mg bid
  • Clarithromycin 500 mg bid
  • Amoxicillin 1 g bid (or metronidazole 500 mg bid if Amoxicillin intolerant)

*RBC has been de-listed in Australlia; However, De-Nol can be substituted for RBC.  De-Nol is Available in Australia Under the TGA's Special Access Scheme (SAS)  Contact Tri-Med Distributors P/L; Email sales@trimed.com.au; Ph. +61 8 9388 1444

 

Other US-FDA-Approved  Dual Therapies


Cure rate 70% at 2 weeks

  • Omeprazole 40 mg qid
  • Clarithromycin 500 mg tid

 

Cure rate 80% at 2 weeks

  • Ranitidine bismuth citrate 400 mg bid
  • Clarithromycin 500 mg tid

 

Common Trade Names for drugs used


Detailed drug information

Trade name

Active Ingredient

(Generic Name)

Manufacturer/Distributor

 

Biaxin, Klacid (Australia)

 

clarithromycin

Abbott

Flagyl (Australia)

 

metronidazole

Generic

Tritec (USA)

 

ranitidine bismuth citrate

Glaxo-Wellcome

Prilosec (USA) , Losec (Australia)

 

omeprazole

Astra-Zeneka / Merck

Prevacid USA); Zoton (Australia)

 

lansoprazole

Lederle

De-Nol (Australia)

 

Peptobismol (USA)

 

Colloidal Bismuth Subcitrate

 

Bismuth Subslicylate

Tri-Med Australia

Furasian

 

Furazolidone

Tri-Med Australia